What Silicon Valley gets wrong about AI
The article critiques Silicon Valley’s belief that increasingly intelligent AI models will resolve major challenges such as drug development. It argues that medicine is constrained more by regulatory processes and costly clinical trials than by a lack of computational capability. The piece highlights evidence like Eroom’s Law to show that scientific tools have not accelerated drug approvals, underscoring the limits of AI without broader systemic changes.
- ▪AI proponents in Silicon Valley often claim that smarter models will solve complex problems like drug discovery, but this view overlooks practical constraints.
- ▪Medical innovation is heavily bottlenecked by lengthy, expensive clinical trials and regulatory requirements that AI cannot eliminate.
- ▪Eroom’s Law demonstrates a long‑term decline in new drug approvals per dollar of R&D despite advances in scientific tools.
- ▪Clinical trial data, which is essential for training effective AI models, remains irreplaceable and must be generated through human studies.
- ▪The article suggests that progress in areas such as housing and healthcare depends more on political will than on technological breakthroughs.
Hacker News (AI / LLM) files mainly under ai. We currently carry 2,840 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Sfstandard |
| Canonical URL | https://sfstandard.com/2026/07/29/myth-ai-intelligence-medicine-regulation/ |
| Publication time | Thu, 30 Jul 2026 01:47:44 +0000 |
| Retrieval time | 2026-07-30T01:53:23.302Z |
| Last seen | 2026-07-30T01:53:23.302Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | Tg-cAkcsUl2y · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
IdeasBusinessWhat Silicon Valley gets wrong about AIAI devotees in SF are convinced that smarter models solve everything. Medicine — and the seven years and $1 billion it takes to get a drug approved — says otherwise.Source: J StudiosBy Ruxandra TesloPublished Jul. 29, 2026at12:24pmShareShareCopy linkto this articleEmail (opens in new tab)Twitter (opens in new tab)Bluesky (opens in new tab)Facebook (opens in new tab)LinkedIn (opens in new tab)Telegram (opens in new tab)WhatsApp (opens in new tab)Reddit (opens in new tab)Close share menu1There are $1 comments on this storyPublished Jul.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Sfstandard.